BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11147485)

  • 1. Monoclonal antibodies in lymphoid neoplasia: principles for optimal combined therapy.
    Maloney GD
    Semin Hematol; 2000 Oct; 37(4 Suppl 7):17-26. PubMed ID: 11147485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of monoclonal antibody therapy with conventional and high-dose treatment: current clinical trials.
    Horning JS
    Semin Hematol; 2000 Oct; 37(4 Suppl 7):27-33. PubMed ID: 11147487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab: a new therapeutic monoclonal antibody for non-Hodgkin's lymphoma.
    Scott SD
    Cancer Pract; 1998; 6(3):195-7. PubMed ID: 9652253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic overview of chemotherapy effects in indolent non-Hodgkin's lymphoma.
    Brandt L; Kimby E; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):213-23. PubMed ID: 11441933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New treatment approaches to indolent non-Hodgkin's lymphoma.
    Seymour JF
    Semin Oncol; 2004 Feb; 31(1 Suppl 2):27-32. PubMed ID: 15042532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing treatment options in indolent non-Hodgkin's lymphoma.
    Solal-Céligny P
    Semin Oncol; 2002 Apr; 29(2 Suppl 6):2-6. PubMed ID: 12040527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Hodgkin's lymphoma in the elderly.
    Caimi PF; Barr PM; Berger NA; Lazarus HM
    Drugs Aging; 2010 Mar; 27(3):211-38. PubMed ID: 20210368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma.
    Fanale MA; Younes A
    Drugs; 2007; 67(3):333-50. PubMed ID: 17335294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab: ongoing and future clinical development.
    Grillo-López AJ; Hedrick E; Rashford M; Benyunes M
    Semin Oncol; 2002 Feb; 29(1 Suppl 2):105-12. PubMed ID: 11842397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monoclonal antibody therapy for non-Hodgkin's lymphoma].
    Paul F; Rossi JF; Cartron G
    Rev Prat; 2010 Jan; 60(1):59-63. PubMed ID: 20222313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6. Report on workshop: EBMT workshop "High dose therapy in aggressive NHL".
    Schmitz N
    Ann Hematol; 2001; 80 Suppl 3():B24-5. PubMed ID: 11757700
    [No Abstract]   [Full Text] [Related]  

  • 12. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
    Marcus R; Hagenbeek A
    Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab salvage following relapse after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma.
    Milojkovic D; Mijovic A; Taylor CG; Mufti GJ; Pagliuca A
    Br J Haematol; 2000 Sep; 110(4):1013-4. PubMed ID: 11054097
    [No Abstract]   [Full Text] [Related]  

  • 14. Ten years of rituximab in NHL.
    Winter MC; Hancock BW
    Expert Opin Drug Saf; 2009 Mar; 8(2):223-35. PubMed ID: 19243307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma.
    Voso MT; Pantel G; Weis M; Schmidt P; Martin S; Moos M; Ho AD; Haas R; Hohaus S
    Br J Haematol; 2000 Jun; 109(4):729-35. PubMed ID: 10929022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab in indolent lymphomas.
    Sousou T; Friedberg J
    Semin Hematol; 2010 Apr; 47(2):133-42. PubMed ID: 20350660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A decade of rituximab: improving survival outcomes in non-Hodgkin's lymphoma.
    Molina A
    Annu Rev Med; 2008; 59():237-50. PubMed ID: 18186705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monoclonal antibody immunotherapy for malignant non-Hodgkin's lymphoma].
    Jourdan E; Richard B
    Presse Med; 2000 Apr; 29(13):717-21. PubMed ID: 10797826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of low-grade B-cell lymphoma with the monoclonal antibody rituximab.
    Dillman RO
    Semin Oncol; 2003 Aug; 30(4):434-47. PubMed ID: 12939712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.